Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avatrombopag to Prevent Post-CAR T-cell Cytopenias
NCT07895017Phase 2Not yet recruiting
- Sponsor
- University of Virginia
- Start
- Nov 2026
- Primary completion
- Aug 2029
- Countries
- 1
01
Overview
A Phase 2 trial of avatrombopag in Thrombocytopenia, sponsored by University of Virginia. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
avatrombopag
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on NCT07895017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07895017.